Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Joann Stetz"'
Autor:
Deborah Watkins Bruner, William Spanos, Joann Stetz, Anthony H. Russell, Patricia J. Eifel, Perry W. Grigsby, Judith A. Stitt, Wui Jin Koh, Jessie Sullivan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 31:1281-1299
The purpose of this article is to review the late effects of cancer therapy on the female reproductive tract. The anatomic sites detailed are the vulva, vagina, cervix, uterus, fallopian tubes, and ovaries. The available pathophysiology is discussed.
Publikováno v:
Quality of Life Research. 3:199-206
The Radiation Therapy Oncology Group (RTOG) has embarked on seven phase II or phase III multicentre clinical trials involving a quality of life component. Each quality of life trial used questionnaires or examinations that have been tested for reliab
Autor:
Joann Stetz, George E. Laramore, Sandra Zink, Lawrence W. Davis, Richard J. Caplan, Moshe H. Maor, R. Douglas Errington, Robert G. Parker, Lester J. Peters, Michele Burnison, Thomas W. Griffin
Publikováno v:
International journal of radiation oncology, biology, physics. 32(3)
Purpose : To compare the efficacy of fast-neutron radiotherapy with that of conventionally fractionated photon therapy in the management of patients with locally advanced squamous cell carcinoma of the head and neck. Methods and Materials : Patients
Autor:
Joann Stetz, Louis D. Lowry, Charles B. Scott, Lawrence W. Davis, Thomas F. Pajak, John R. Jacobs, Peter H. Blitzer, D. Phil, Richard Chandler, James B. Snow, Victor A. Marcial, Leslie Tupchong, Simon Kramer
Publikováno v:
International journal of radiation oncology, biology, physics. 20(1)
This is a report of a 10-year median follow-up of a randomized, prospective study investigating the optimal sequencing of radiation therapy (RT) in relation to surgery for operable advanced head and neck cancer. In May 1973, the Radiation Therapy Onc
Publikováno v:
Controlled Clinical Trials. 19:S64-S65
Autor:
Martha W. Turner, JoAnn Stetz
Publikováno v:
Controlled Clinical Trials. 14:432
Autor:
Steven Leibel, Jeannie J. Kinzie, Muhyi Al-Sarraf, Lawrence W. Davis, John R. Jacobs, JoAnn Stetz, Thomas F. Pajak, George E. Laramore
Publikováno v:
American Journal of Clinical Oncology. 12:185-189
The feasibility of chemotherapy of three courses of cis-platin and 120-h 5-fluorouracil (5-FU) infusion after definitive surgery, followed by standard radiotherapy, in patients with resectable locally advanced head and neck cancer was carried out in
Autor:
Todd H. Wasserman, John Fazekas, Marvin Rotman, Simon Kramer, Thomas F. Pajak, Victor A. Marcial, Joann Stetz, Lawrence C. Davis
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 13:1155-1160
As part of the RTOG research effort in the treatment of advanced, inoperable squamous cancer of the head and neck region, the hypoxic cell sensitizer, misonidazole, was selected for investigation as an adjuvant to definitive irradiation. Based upon a
Autor:
Thomas F. Pajak, Muhyi Al-Sarraf, Joann Stetz, Jay S. Cooper, Phyllis Ager Mowry, Enrique Velez-Garcia, John F. Ensley, Victor A. Marcial
Publikováno v:
Cancer. 59:259-265
In patients who have locally advanced and inoperable head and neck cancer, the achievement of initial local control (complete response) of the disease with initial definitive treatment with radiotherapy (RT) with or without chemotherapy, is an import
Publikováno v:
International journal of radiation oncology, biology, physics. 13(1)
From August 1979 to June 1983, the RTOG conducted a prospective Phase III study that compared a standard schedule with five fractions per week of 180 to 200 cGy per day to a total dose of 6600-7380 cGy, with a hyperfractionation regimen consisting of